-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BdqA3jsZc8z8zBggOtajuh4Ci+I7ah4GXrkexNJHemKUSOWASisrKoAjhRHuG56D kOrkEHKeCIwAZRSM+m2i7Q== 0001013594-09-001341.txt : 20090702 0001013594-09-001341.hdr.sgml : 20090702 20090702164727 ACCESSION NUMBER: 0001013594-09-001341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090630 FILED AS OF DATE: 20090702 DATE AS OF CHANGE: 20090702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 09928088 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 4 1 bdsifm4-070309_ex.xml JULY 3, 2009 X0303 4 2009-06-30 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0000904495 ELLIOTT ASSOCIATES, L.P. 712 FIFTH AVE NEW YORK NY 10019 0 0 1 0 Common Stock 2009-06-30 4 S 0 32640 6.6764 D 299074 I See Common Stock 2009-07-01 4 S 0 50000 6.7552 D 249074 I See Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation ("Manchester"), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. ("BDSI"), owned by CDC IV, LLC ("CDC IV"). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager's rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV. On June 30, 2009, CDC IV sold an aggregate of 32,640 shares of Common Stock of BDSI at an average gross price per share of $6.6764. The individual trades made by CDC IV on June 30, 2009 are set forth on Exhibit 1(a) attached hereto. On July 1, 2009, CDC IV sold an aggregate of 50,000 shares of Common Stock of BDSI at an average gross price per share of $6.7552. The individual trades made by CDC IV on July 1, 2009 are set forth on Exhibit 1(b) attached hereto. Elliot Greenberg, VP of Braxton Associates, Inc., as GP of Elliott Capital Advisors, L.P., as GP of Elliott Associates, L.P. 2009-07-02 EX-99 2 bdsiex99-070309.htm JULY 3, 2009

EXHIBIT 1(a)

Trades on June 30, 2009

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.   Title of Security
(Instr. 3)

2. Transaction Date

2A.Deemed Execution Date, if any

3.Transaction Code (Instr. 8)

4.   Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

5. Amount of
Securities Beneficially
Owned Following

6. Ownership Form: Direct (D) or

 

7.Nature of Indirect Beneficial Ownership

 

(Month/
Day/
Year)

(Month/
Day/
Year)

 

Code

 

V

 

Amount

(A)or (D)

 

Price

 

Reported
Transaction(s)

(Instr. 3 and 4)

Indirect (I)

(Instr. 4)

 

(Instr. 4)

Common Stock

6/30/2009

 

S

 

100

D

$6.8050

331,614

I

(1)

Common Stock

6/30/2009

 

S

 

400

D

$6.8025

331,214

I

(1)

Common Stock

6/30/2009

 

S

 

600

D

$6.8000

330,614

I

(1)

Common Stock

6/30/2009

 

S

 

600

D

$6.7700

330,014

I

(1)

Common Stock

6/30/2009

 

S

 

100

D

$6.7650

329,914

I

(1)

Common Stock

6/30/2009

 

S

 

100

D

$6.7625

329,814

I

(1)

Common Stock

6/30/2009

 

S

 

1,500

D

$6.7600

328,314

I

(1)

Common Stock

6/30/2009

 

S

 

4,240

D

$6.7500

324,074

I

(1)

Common Stock

6/30/2009

 

S

 

1,300

D

$6.6600

322,774

I

(1)

Common Stock

6/30/2009

 

S

 

23,700

D

$6.6500

299,074

I

(1)

 

(1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation (“Manchester”), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. (“BDSI”), owned by CDC IV, LLC (“CDC IV”). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager’s rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV.

 

EXHIBIT 1(b)

Trades on July 1, 2009

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.   Title of Security
(Instr. 3)

2. Transaction Date

2A.Deemed Execution Date, if any

3.Transaction Code (Instr. 8)

4.Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

5. Amount of
Securities Beneficially
Owned Following

6. Ownership Form: Direct (D) or

 

7.Nature of Indirect Beneficial Ownership

 

(Month/
Day/
Year)

(Month/
Day/
Year)

 

Code

 

V

 

Amount

(A)or (D)

 

Price

 

Reported
Transaction(s)

(Instr. 3 and 4)

Indirect (I)

(Instr. 4)

 

(Instr. 4)

Common Stock

07/01/09

 

S

 

2,331

D

$6.8000

296,743

I

(1)

Common Stock

07/01/09

 

S

 

1,100

D

$6.7900

295,643

I

(1)

Common Stock

07/01/09

 

S

 

100

D

$6.7750

295,543

I

(1)

Common Stock

07/01/09

 

S

 

1,980

D

$6.7700

293,563

I

(1)

Common Stock

07/01/09

 

S

 

5,863

D

$6.7600

287,700

I

(1)

Common Stock

07/01/09

 

S

 

100

D

$6.7550

287,600

I

(1)

Common Stock

07/01/09

 

S

 

38,526

D

$6.7500

249,074

I

(1)

 

(1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation (“Manchester”), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. (“BDSI”), owned by CDC IV, LLC (“CDC IV”). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager’s rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV.

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----